By GINA KOLATA
A new study suggests that biotech companies are spending far less than believed on research and development for approved drugs, despite rising prices.
Published: September 10, 2017 at 08:00PM
from NYT Health http://ift.tt/2vPB8zT
via IFTTT
from WordPress http://ift.tt/2gYrF2N
via IFTTT
No comments:
Post a Comment